Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Cash from Investing Activities (2022 - 2026)

Zentalis Pharmaceuticals has reported Cash from Investing Activities over the past 5 years, most recently at $30.0 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 25.85% year-over-year to $30.0 million; the TTM value through Mar 2026 reached $121.2 million, down 22.08%, while the annual FY2025 figure was $131.6 million, 25.45% down from the prior year.
  • Cash from Investing Activities for Q1 2026 was $30.0 million at Zentalis Pharmaceuticals, down from $32.4 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $72.9 million in Q2 2023 and troughed at -$142.1 million in Q2 2022.
  • A 5-year average of $10.6 million and a median of $30.4 million in 2025 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 686.73% in 2023 and later skyrocketed 176.75% in 2024.
  • Year by year, Cash from Investing Activities stood at -$11.9 million in 2022, then tumbled by 253.62% to -$42.1 million in 2023, then soared by 176.75% to $32.3 million in 2024, then grew by 0.51% to $32.4 million in 2025, then dropped by 7.5% to $30.0 million in 2026.
  • Business Quant data shows Cash from Investing Activities for ZNTL at $30.0 million in Q1 2026, $32.4 million in Q4 2025, and $28.3 million in Q3 2025.